Skip to main content
. 2016 Feb 27;43:1585–1592. doi: 10.1007/s00259-016-3328-2

Fig. 1.

Fig. 1

Disease course according to primary site (CR complete response, PR partial remission, SD stable disease, PD progressive disease) *p < 0.05 as compared with SD and PR; Δ p < 0.05 as compared with PD